Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-829-8 | CAS number: 7758-01-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The genotoxicty of potassium bromate was studied in numerous assays in vitro and in vivo and the results are available in published literature. Summaries of those data have been generated by WHO, IARC and other expert committees. Below a short overview of the data is given that provides key information.
Bromate was mutagenic in Salmonella typhimurium strains (TA100, TA1535 and TA97) and produced chromosomal aberrations in cultured Chinese hamster fibroblast cells [1, 2]. In assays using V79 Chinese hamster ovary cells, bromate increased the frequency of micronucleated cells, the number of DNA strand breaks and the number of chromosomal aberrations. Furthermore, potassium bromate induced gene mutations in the HPRT locus [3]. Gentox studies using different cell lines and protocols have shown only little or no DNA damage in standard alkaline Comet assays [4].
Positive results were also observed in in vivo studies. Following single oral doses of potassium bromate in Long-Evans rats, the number of aberrant metaphase cells was increased [5], Intraperitoneal injection or gavage dosing in mice leads to elevated numbers of micronuclei with MS/Ae and CD-1 mice strains [6-9]. After intraperitoneal injection of bromate in F344 rats the number of micronuclei in reticulocytes was significantly increased [10]. Finally, evidence of DNA damage has been observed in rats orally administered potassium bromate [11].
The weight of evidence demonstrates that bromate is clearly mutagenic in in vitro assays.
The positive findings in in vivo studies show that this mutagenicity is also expressed in vivo.
References
1. Zeiger, E., et al., Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environmental & Molecular Mutagenesis, 1992. 19 Suppl 21: p. 2-141.
2. Ishidate, M., Jr., et al., Primary mutagenicity screening of food additives currently used in Japan. Food & Chemical Toxicology, 1984. 22(8): p. 623-36.
3. Speit, G., et al., Comparative evaluation of the genotoxic properties of potassium bromate and potassium superoxide in V79 Chinese hamster cells. Mutation Research, 1999. 439(2): p. 213-21.
4. Priestley, C.C., et al., Anomalous genotoxic responses induced in mouse lymphoma L5178Y cells by potassium bromate. Toxicology, 2010. 267(1-3): p. 45-53.
5. Fujie, K., et al., Acute cytogenetic effects of potassium bromate on rat bone marrow cells in vivo. Mutation Research, 1988. 206(4): p. 455-8.
6. Hayashi, M., et al., Difference between intraperitoneal and oral gavage application in the micronucleus test. The 3rd collaborative study by CSGMT/JEMS.MMS. Collaborative Study Group for the Micronucleus Test/Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan. Mutation Research, 1989. 223(4): p. 329-44.
7. Hayashi, M., et al., Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. Food & Chemical Toxicology, 1988. 26(6): p. 487-500.
8. Nakajima, M., et al., Effect of route of administration in the micronucleus test with potassium bromate. Mutation Research, 1989. 223(4): p. 399-402.
9. Awogi, T., et al., Induction of micronucleated reticulocytes by potassium bromate and potassium chromate in CD-1 male mice. Mutation Research, 1992. 278(2-3): p. 181-5.
10. Sai, K., et al., Effects of antioxidants on induction of micronuclei in rat peripheral blood reticulocytes by potassium bromate. Mutation Research, 1992. 269(1): p. 113-8.
11. Kasai, H., et al., Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis, 1987. 8(12): p. 1959-61.
Short description of key information:
1) in vitro assays:
- Gene mutation in bacteria (Bacterial Reverse Mutation Assay/Ames): mutagenic in TA 1535, TA97, weakly mutagenic in TA100.
- CA in Chinese hamster fibroblast cells: mutagenic
- CA, MNT, DNA damage/repair and Comet assays in V79 Chinese hamster cells: mutagenic
2) in vivo assays
- MNT, HPRT, CA: positive
Endpoint Conclusion: Adverse effect observed (positive)
Justification for classification or non-classification
Provided key and supporting studies with potassium bromate did clearly show genotoxic potential in vitro and in vivo. This summary reveals some background information on the legal classification for carcinogenicity (see chapter 7.7). Further legal classification for germ cell mutagenicity is not rewarded.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.